Genomics Medicine to create up to 600 jobs in Dublin

28 November, 2018

An Irish life sciences company is to create 600 high-skilled jobs in Dublin over the next five years, as a result of an investment of up to €350m. The expansion will enable Genomics Medicine Ireland to speed up plans to map the genetic blueprint of 400,000 people in Ireland in the search for better diagnostics and treatments for a range of illnesses.

An Irish life sciences company is to create 600 high-skilled jobs in Dublin over the next five years, as a result of an investment of up to €350m.

The expansion will enable Genomics Medicine Ireland to speed up plans to map the genetic blueprint of 400,000 people in Ireland in the search for better diagnostics and treatments for a range of illnesses.
As part of the plan, GMI will become an independent subsidiary of US firm WuXi NextCode, a company that makes a technology platform for genetic sequencing.

A number of investors, including the State-backed Irish Strategic Investment Fund, will also inject funding into GMI.

"We see the potential for significant skilled job creation and great commercial returns as well," said Paul Saunders, Senior Investment Director at ISIF, "So it is a very good fit with the bottom line of commercial return and economic impact."

To read the full article on RTE.ie click HERE